--- mi_id: MILV-fr-MIPR-node_74f74ee type: press_release canonical_url: "https://www.pheonixresearch.com/fr/healthcare/healthcare-pharmaceuticals/press-release/global-liquid-chromatography-mass-spectrometry-lc-ms-market/" md_url: "https://www.pheonixresearch.com/fr/healthcare/healthcare-pharmaceuticals/press-release/global-liquid-chromatography-mass-spectrometry-lc-ms-market.md" schema: "@type": NewsArticle "@id": MILV-fr-MIPR-node_74f74ee url: "https://www.pheonixresearch.com/fr/healthcare/healthcare-pharmaceuticals/press-release/global-liquid-chromatography-mass-spectrometry-lc-ms-market/" inLanguage: fr translationOfWork: "@id": MIPR-node_74f74ee url: "https://www.pheonixresearch.com/healthcare/healthcare-pharmaceuticals/press-release/global-liquid-chromatography-mass-spectrometry-lc-ms-market/" title: "Pheonix Research publie le 2026 \"Global Liquid Chromatography Mass Spectrometry (LC-MS) Market Outlook – Communiqué de presse\"" description: "Le marché mondial de la chromatographie en phase liquide couplée à la spectrométrie de masse (LC-MS) est estimé passer de 5,85 milliards de dollars en 2025 à 10,75 milliards de dollars d'ici 2033, à un taux de croissance annuelle composé (CAGR) de 7,90%" datePublished: "2026-07-04T16:37:07+00:00" dateModified: "2026-07-12T08:34:33+00:00" keywords: - Marché mondial de la chromatographie en phase liquide couplée à la spectrométrie de masse - marché LC-MS - taille du marché de la chromatographie en phase liquide couplée à la spectrométrie de masse - part de marché LC-MS - prévision du marché LC-MS - systèmes LC-MS à haute résolution - marché de la spectrométrie de masse - marché des équipements analytiques - tests analytiques pharmaceutiques - diagnostics cliniques LC-MS - marché de la protéomique - marché de la métabolomique - "rapport sur l'industrie LC-MS 2026-2033" isPartOf: - id: MISG-node_a5546f7 type: CollectionPage url: "https://www.pheonixresearch.com/healthcare/healthcare-pharmaceuticals/" name: santé et pharmaceutique - id: MILV-fr-MIIN-node_50b4dbf type: CollectionPage url: "https://www.pheonixresearch.com/fr/healthcare/" name: Industrie de la santé - id: MIWS-root type: WebSite url: "https://www.pheonixresearch.com/" name: Pheonix Research acf: phoenix_meta_title: "Global Liquid Chromatography Mass Spectrometry (LC-MS) Market " phoenix_meta_description: "The Global Liquid Chromatography Mass Spectrometry (LC-MS) Market is projected to grow from USD 5.85 billion in 2025 to USD 10.75 billion by 2033, at a CAGR of 7.90%" global_schema: organization: "@id": MIWS-root#organization "@type": Organization url: "https://www.pheonixresearch.com/" name: Pheonix Research website: "@id": MIWS-root "@type": WebSite url: "https://www.pheonixresearch.com/" name: Pheonix Research api: "@id": MIWS-root#api "@type": WebAPI url: "https://www.pheonixresearch.com/" graph: node_id: MILV-fr-MIPR-node_74f74ee graph_node_endpoint: "https://graph.pheonixresearch.com/api/v1/query/live/node/MILV-fr-MIPR-node_74f74ee" graph_snapshot: "https://graph.pheonixresearch.com/api/v1/read/live/graph" graph_exclusions: "https://graph.pheonixresearch.com/api/v1/read/live/exclusions" graph_meta: "https://graph.pheonixresearch.com/api/v1/read/live/meta" graph_bundle: "https://graph.pheonixresearch.com/api/v1/read/live/bundle" discovery: discovery_json: "https://www.pheonixresearch.com/.well-known/pheonix-discovery.json" llms_txt: "https://www.pheonixresearch.com/llms.txt" sitemap: "https://www.pheonixresearch.com/sitemap.xml" --- # Pheonix Research publie le 2026 "Global Liquid Chromatography Mass Spectrometry (LC-MS) Market Outlook – Communiqué de presse" Global Liquid Chromatography Mass Spectrometry (LC-MS) Market to Reach USD 10.75 Billion by 2033 Amid Rising Pharmaceutical Research, High-Resolution Mass Spectrometry & AI-Driven Analytical Workflows July 2026 | Pheonix Market Research The Global Liquid Chromatography Mass Spectrometry (LC-MS) Market is projected to grow from USD 5.85 Billion in 2025 to approximately USD 10.75 Billion by 2033, registering a CAGR of 7.90% during the forecast period of 2026-2033, according to the latest market intelligence report published by Pheonix Market Research. The market is experiencing robust growth driven by expanding pharmaceutical and biotechnology research, increasing demand for highly sensitive analytical technologies, growing applications in clinical diagnostics, food safety testing, environmental monitoring, and rapid advancements in high-resolution mass spectrometry systems. Rising investments in drug discovery, precision medicine, biomarker identification, proteomics, metabolomics, and personalized healthcare continue to strengthen the adoption of LC-MS platforms across research laboratories and industrial testing facilities worldwide. The industry is also benefiting from continuous innovation in high-resolution mass spectrometry, AI-powered data analysis, cloud-enabled laboratory platforms, workflow automation, and integrated analytical software. Instrument manufacturers are developing next-generation LC-MS systems capable of delivering superior sensitivity, faster sample throughput, improved molecular characterization, and enhanced data interpretation. The integration of artificial intelligence, machine learning, and automated sample preparation technologies is significantly improving laboratory productivity while reducing analytical complexity and turnaround times. Growing regulatory requirements across pharmaceutical manufacturing, clinical testing, environmental analysis, and food quality assurance are further accelerating market expansion. Compliance with FDA, EMA, GLP/GMP guidelines, and laboratory quality standards continues to drive investments in advanced analytical instrumentation capable of delivering highly accurate, reproducible, and regulatory-compliant results. Increasing demand for contaminant detection, toxicology testing, therapeutic drug monitoring, and forensic analysis is further broadening the application scope of LC-MS technologies. According to Pheonix Market Research, continuous advancements in high-resolution instrumentation, intelligent analytical software, laboratory automation, and omics research are expected to create significant growth opportunities throughout the forecast period as organizations increasingly prioritize analytical precision, operational efficiency, and regulatory compliance. Asia-Pacific is anticipated to emerge as the fastest-growing regional market due to expanding biotechnology industries, increasing pharmaceutical manufacturing, rising healthcare investments, growing academic research activities, and strong government support for scientific innovation. North America continues to dominate the global market owing to its advanced life sciences ecosystem, strong pharmaceutical and biotechnology sectors, extensive R&D investments, and widespread adoption of next-generation analytical technologies. A Senior Analytical Instruments & Life Sciences Analyst at Pheonix Market Research stated: Liquid chromatography mass spectrometry continues to evolve as one of the most indispensable analytical technologies across pharmaceutical research, clinical diagnostics, and advanced life sciences. The convergence of high-resolution mass spectrometry, artificial intelligence, automation, and cloud-based laboratory ecosystems is enabling faster, more accurate molecular analysis while improving laboratory efficiency. As precision medicine, biomarker discovery, and omics research continue expanding globally, LC-MS technologies will remain central to next-generation analytical science. Key Market Highlights LC-MS Instruments remain the largest market segment due to their extensive deployment across pharmaceutical research, biotechnology, clinical diagnostics, and analytical laboratories. High-Resolution LC-MS Systems represent the fastest-growing segment driven by increasing demand for proteomics, metabolomics, biomarker discovery, and precision medicine applications. Pharmaceutical & Biotechnology Companies continue to account for the leading end-use segment globally. Growing pharmaceutical R&D investments are accelerating adoption of advanced LC-MS platforms for drug discovery, biologics development, and quality assurance. AI-enabled analytical software and laboratory automation are improving data interpretation, workflow efficiency, and analytical productivity. Increasing regulatory testing requirements in food safety, environmental monitoring, forensic science, and clinical laboratories continue supporting long-term market expansion. High-resolution mass spectrometry and integrated laboratory informatics are transforming analytical workflows across research and industrial laboratories. Report Highlights Market Size (2025): USD 5.85 Billion Market Size (2033): USD 10.75 Billion CAGR (2026-2033): 7.90% Largest Segment: LC-MS Instruments Fastest Growing Segment: High-Resolution LC-MS Systems Leading End-Use Segment: Pharmaceutical & Biotechnology Companies Key Trend: High-Resolution Mass Spectrometry, AI-Based Data Analysis & Automation in Analytical Workflows About Pheonix Market Research Pheonix Market Research is a global market intelligence and strategic advisory firm specializing in healthcare, medical devices, life sciences, biotechnology, pharmaceuticals, diagnostics, analytical instrumentation, and emerging healthcare technologies. The firm delivers comprehensive market intelligence, competitive analysis, industry forecasting, and strategic consulting services that enable healthcare organizations, life science companies, analytical instrument manufacturers, investors, and policymakers to make informed decisions across rapidly evolving global markets. For detailed insights and full report access: Website: https://www.pheonixresearch.com/healthcare/healthcare-pharmaceuticals/market-report/global-liquid-chromatography-mass-spectrometry-lc-ms-market/ Media Contact Pheonix Market Research Email: media@pheonixmarketresearch.com Website: www.pheonixmarketresearch.com